alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › imaging-biomarkers

imaging-biomarkers

6 studies tagged imaging-biomarkers, dated 2015-12-22 to 2023-12-09. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification 2023-12-09
  2. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers 2020-08-06
  3. The A/T/N model applied through imaging biomarkers in a memory clinic 2019-12-02

Studies

6 studies carry this tag.

Date range

2015 to 2023

Top journals

  • Alzheimer's & dementia (Amsterdam, Netherlands) 2
  • European journal of nuclear medicine and molecular imaging 1
  • Human brain mapping 1
  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1
  • Neurobiology of disease 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification

    ✓ Peer-reviewed alzhub usefulness score 69 out of 100. Neurobiology of disease 2023-12-09 Genetics

    In Alzheimer's disease (AD) research, cerebrospinal fluid (CSF) Amyloid beta (Aβ), Tau and pTau are the most accepted and well validated biomarkers.

  2. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020-08-06 Brain scans and imaging

    PET neuroimaging of amyloid-β (Aβ) provides an in vivo biomarker for pathologic changes associated with Alzheimer disease (AD).

  3. The A/T/N model applied through imaging biomarkers in a memory clinic

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. European journal of nuclear medicine and molecular imaging 2019-12-02 Brain scans and imaging

    Medial and lateral temporal regions represent a site of significant tau accumulation in A+ subjects and possibly a useful marker of early clinical changes.

  4. Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Human brain mapping 2018-10-19 Brain scans and imaging

    Previous positron emission tomography (PET) studies have quantified filamentous tau pathology using regions-of-interest (ROIs) based on observations of the topographical distribution of neurofibrillary tangles in post-mortem tissue.

  5. Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2017-04-23 Biomarkers

    These data suggest that apoJ may have potential in the context of use (COU) of AD diagnostics, I-309 may be specifically useful in the COU of identifying individuals at greatest risk for progressing toward AD.

  6. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2015-12-22 Biomarkers

    Mean apoJ levels were significantly higher in both MCI and AD groups.

All topic tags with their study counts